Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

18 Stocks Moving In Wednesday's Pre-Market Session

LOGI, LUV, JNPR, GRMN, AAPL, AKAM, KO, CMG


Gainers

  • OncoGenex Pharmaceuticals Inc (NASDAQ: OGXI) rose 27 percent to $0.471 in pre-market trading after the company disclosed that its Phase 2 Borealis trial met primary endpoint of overall survival.
  • Akamai Technologies, Inc. (NASDAQ: AKAM) rose 16.1 percent to $68.60 in the pre-market trading session after the company posted upbeat quarterly results.
  • Logitech International SA (USA) (NASDAQ: LOGI) shares rose 12.7 percent to $24.23 in pre-market trading on upbeat quarterly results.
  • Apricus Biosciences Inc (NASDAQ: APRI) shares rose 10.2 percent to $2.70 in pre-market trading after the company reported the approval of Vitaros for the treatment of erectile dysfunction in Greece.
  • Lightinthebox Holding Co Ltd-ADR (NYSE: LITB) rose 8.6 percent to $2.92 in pre-market trading after gaining 0.37 percent on Tuesday.
  • Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) rose 7.9 percent to $84.90 in pre-market trading after the company reported Q3 results and announced the planned initiation of Phase 2 studies evaluating the next-generation correctors VX-440 and VX-152 in triple combination regimens..
  • Garmin Ltd. (NASDAQ: GRMN) shares rose 6.7 percent to $52.80 in pre-market trading after the company posted upbeat quarterly earnings and raised its guidance.
  • Juniper Networks, Inc. (NYSE: JNPR) rose 4.6 percent to $24.81 in the pre-market trading after the company reported better-than-expected quarterly results.
  • The Coca-Cola Co (NYSE: KO) rose 2 percent to $43.33 in pre-market trading after the company reported earnings and revenue that came in higher than the estimates.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • Edwards Lifesciences Corp (NYSE: EW) shares fell 11.9 percent to $100.18 in the pre-market trading session on weak sales for the third quarter.
  • Weatherford International Plc (NYSE: WFT) shares fell 10.7 percent to $5.50 in pre-market trading after the company posted a wider-than-expected quarterly loss.
  • Collegium Pharmaceutical Inc (NASDAQ: COLL) shares fell 8.4 percent to $15.45 in pre-market trading after the company announced a proposed public offering of common stock.
  • Pandora Media Inc (NYSE: P) fell 8.2 percent to $11.18 in pre-market trading after the company posted a wider-than-expected loss for its third quarter on Tuesday. Total listener hours grew by 5 percent year-over-year to 5.4 billion.
  • Southwest Airlines Co (NYSE: LUV) shares fell 7 percent to $39.00 in pre-market trading after the company reported mixed results for the third quarter. While EPS topped, revenue fell shy of expectations modestly.
  • Diplomat Pharmacy Inc (NYSE: DPLO) fell 6.5 percent to $27.00 in pre-market trading. Diplomat Pharmacy named Paul Urick as President, while Gary Kadlec will retire on December 31, 2016. The company also disclosed that Sean Whelan will step down as CFO.
  • Six Flags Entertainment Corp (NYSE: SIX) shares fell 6.2 percent to $48.07 in pre-market trading on downbeat quarterly earnings.
  • Chipotle Mexican Grill, Inc. (NYSE: CMG) shares fell 4.1 percent to $388.99 in pre-market trading after the company announced weaker-than-expected results for its third quarter.
  • Apple Inc. (NASDAQ: AAPL) shares fell 2.8 percent to $114.90 in pre-market trading. Apple reported better-than-expected earnings for its fourth quarter. However, revenue of $46.9 billion, down 8.9 percent year-over-year, was in line with expectations.


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today